1.43
price up icon0.00%   0.00
after-market Handel nachbörslich: 1.42 -0.01 -0.70%
loading

Finanzdaten der Acrivon Therapeutics Inc-Aktie (ACRV)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
16.08%
17.67
21.05 16.14 15.52 14.39
Operating Income/Loss
16.08%
-17.67
-21.05 -16.14 -15.52 -14.39
Nonoperating Income/Loss
1.182
- 1.671 1.606 1.637
Income/Loss From Continuing Operations Before Tax
14.37%
-16.49
-19.25 -14.47 -13.91 -12.76
Income/Loss From Continuing Operations After Tax
14.37%
-16.49
-19.25 -14.47 -13.91 -12.76
Net Income/Loss
14.37%
-16.49
-19.25 -14.47 -13.91 -12.76
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
25,962%
22.59
0.0867 22.08 21.97 21.92
Diluted Average Shares
25,962%
22.59
0.0867 22.08 21.97 21.92
Basic Earnings Per Share
16.09%
-0.73
-0.87 -0.66 -0.63 -0.58
Diluted Earnings Per Share
16.09%
-0.73
-0.87 -0.66 -0.63 -0.58
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.26%
$112.79
price down icon 2.19%
biotechnology ONC
$294.51
price up icon 1.04%
Kapitalisierung:     |  Volumen (24h):